{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:14:03Z","timestamp":1791000843191,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.preghy.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:29:53Z","timestamp":1512523793000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Apparent systemic 11\u00df-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction"],"prefix":"10.1016","volume":"11","author":[{"given":"M.","family":"Vasku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kleine-Eggebrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Mohaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Escher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pecks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.preghy.2017.11.012_b0005","first-page":"950","article-title":"Preeclampsia and fetal growth","volume":"96","author":"\u00d8deg\u00e5rd","year":"2000","journal-title":"Obstet. Gynecol."},{"issue":"20","key":"10.1016\/j.preghy.2017.11.012_b0010","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199611143352002","article-title":"Preeclampsia\u2014a state of sympathetic overactivity","volume":"335","author":"Schobel","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.preghy.2017.11.012_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2362.2004.01350.x","article-title":"Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia","volume":"34","author":"Fischer","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/edrv-11-1-124","article-title":"Placental steroid hormone biosynthesis in primate pregnancy","volume":"11","author":"Albrecht","year":"1990","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.preghy.2017.11.012_b0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ncpendmet0515","article-title":"Mechanisms of disease: glucocorticoids, their placental metabolism and fetal'programming'of adult pathophysiology","volume":"3","author":"Seckl","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.preghy.2017.11.012_b0030","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/endo.135.6.7988446","article-title":"Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: enhancement of fetal pituitary proopiomelanocortin messenger ribonucleic acid expression","volume":"135","author":"Pepe","year":"1994","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.preghy.2017.11.012_b0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1203\/00006450-197305000-00004","article-title":"The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term","volume":"7","author":"Beitins","year":"1973","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0303-7207(01)00624-4","article-title":"The fetal placental hypothalamic\u2013pituitary\u2013adrenal (HPA) axis, parturition and post natal health","volume":"185","author":"Challis","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.preghy.2017.11.012_b0045","doi-asserted-by":"crossref","unstructured":"Rees, L.H., Burke, C.W., Chard, T., Evans, S.W., Letchworth, A.T., 1975. Possible placental origin of ACTH in normal human pregnancy.","DOI":"10.1038\/254620b0"},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12958-015-0100-6","article-title":"Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum","volume":"13","author":"Mistry","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2002-021378","article-title":"Placental 11\u03b2-hydroxysteroid dehydrogenase-2 and fetal cortisol\/cortisone shuttle in small preterm infants","volume":"88","author":"Kajantie","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.preghy.2017.11.012_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.placenta.2007.10.010","article-title":"Placental 11\u03b2-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery","volume":"29","author":"Dy","year":"2008","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2017.11.012_b0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000235879","article-title":"Differential expression and activity of 11\u03b2-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction","volume":"25","author":"W\u00e4chter","year":"2009","journal-title":"Fetal Diagn. Ther."},{"issue":"10","key":"10.1016\/j.preghy.2017.11.012_b0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0039-128X(98)00056-7","article-title":"Placental 11\u03b2-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies","volume":"63","author":"McCalla","year":"1998","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.preghy.2017.11.012_b0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0897.2012.01157.x","article-title":"Anti-oxidized Low-Density Lipoprotein (oxLDL) Antibody Levels are not Related to Increasing Circulating oxLDL Concentrations During the Course of Pregnancy","volume":"68","author":"Pecks","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"07","key":"10.1016\/j.preghy.2017.11.012_b0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0042-107078","article-title":"Maternal serum lipid, estradiol, and progesterone levels in pregnancy, and the impact of placental and hepatic pathologies","volume":"76","author":"Pecks","year":"2016","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0085","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the national high blood pressure education program working group on high blood pressure in pregnancy","volume":"183","author":"Program","year":"2000","journal-title":"Am. J. Obstetrics Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2017.11.012_b0090","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000429658.85846.f9","article-title":"134: fetal growth restriction","volume":"121","author":"ACOG Practice bulletin no","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12944-016-0365-6","article-title":"Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction","volume":"15","author":"Pecks","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.preghy.2017.11.012_b0100","unstructured":"World Health Organization, WHO guidelines on drawing blood: best practices in phlebotomy, 2010."},{"issue":"5","key":"10.1016\/j.preghy.2017.11.012_b0105","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.2010-2395","article-title":"A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum","volume":"96","author":"Jung","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.preghy.2017.11.012_b0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/humrep\/13.4.799","article-title":"11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction","volume":"13","author":"Shams","year":"1998","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.preghy.2017.11.012_b0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1450187","article-title":"Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation","volume":"145","author":"Schoof","year":"2001","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0303-7207(01)00633-5","article-title":"Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms","volume":"185","author":"Seckl","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9656","key":"10.1016\/j.preghy.2017.11.012_b0125","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(08)61929-7","article-title":"Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial","volume":"372","author":"Murphy","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.preghy.2017.11.012_b0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1203\/PDR.0b013e31818d6c24","article-title":"Prematurity is related to high placental cortisol in preeclampsia","volume":"65","author":"Aufdenblatten","year":"2009","journal-title":"Pediatr. Res."},{"issue":"11","key":"10.1016\/j.preghy.2017.11.012_b0135","first-page":"5222","article-title":"Alteration of the activity of the 11\u03b2-hydroxysteroid dehydrogenase in pregnancy: Relevance for the development of pregnancy-induced hypertension?","volume":"86","author":"Heilmann","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.preghy.2017.11.012_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144343","article-title":"Glucocorticoid metabolism in hypertensive disorders of pregnancy: analysis of plasma and urinary cortisol and cortisone","volume":"10","author":"Kosicka","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.preghy.2017.11.012_b0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0008-6363(97)00299-X","article-title":"The role of 11\u03b2-hydroxysteroid dehydrogenase in the pathogenesis of hypertension","volume":"38","author":"van Uum","year":"1998","journal-title":"Cardiovasc. Res."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917300600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917300600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:50Z","timestamp":1761897050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917300600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"alternative-id":["S2210778917300600"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2017.11.012","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apparent systemic 11\u00df-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}